Juge-Morineau N - Search Results

1

Immunoglobulins D and M multiple myeloma variants are heavily mutated.

Juge-Morineau N, Heirman C, Bakkus M, Van Camp B, Malfait R, Harousseau JL, Thielemans K, Bataille R. Juge-Morineau N, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2501-6. Clin Cancer Res. 1997. PMID: 9815653

2

Detection of minimal residual disease in multiple myeloma and acute leukaemia.

Bakkus MH, Juge-Morineau N, van der Werff ten Bosch JE. Bakkus MH, et al. Med Oncol. 1996 Jun;13(2):121-31. doi: 10.1007/BF02993863. Med Oncol. 1996. PMID: 9013476 Review.

3

Persistence of residual tumour cells after cytokine-mediated ex vivo expansion of mobilized CD34+ blood cells in multiple myeloma.

Van Riet I, Juge-Morineau N, Schots R, De Waele M, De Greef C, Thielemans K, Van Camp B, Bakkus M. Van Riet I, et al. Br J Haematol. 1997 Feb;96(2):403-11. doi: 10.1046/j.1365-2141.1997.d01-2038.x. Br J Haematol. 1997. PMID: 9029033 Free article.

4

[Role of glucocorticoids in the treatment of multiple myeloma].

Juge-Morineau N, Harousseau JL, Bataille R. Juge-Morineau N, et al. Ann Med Interne (Paris). 1996;147(8):576-9. Ann Med Interne (Paris). 1996. PMID: 9137685 Review. French.

5

The retinoblastoma susceptibility gene RB-1 in multiple myeloma.

Juge-Morineau N, Harousseau JL, Amiot M, Bataille R. Juge-Morineau N, et al. Leuk Lymphoma. 1997 Jan;24(3-4):229-37. doi: 10.3109/10428199709039011. Leuk Lymphoma. 1997. PMID: 9156653 Review.

6

Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma.

Moreau P, Milpied N, Mahé B, Juge-Morineau N, Rapp MJ, Bataille R, Harousseau JL. Moreau P, et al. Among authors: juge morineau n. Bone Marrow Transplant. 1999 May;23(10):1003-6. doi: 10.1038/sj.bmt.1701763. Bone Marrow Transplant. 1999. PMID: 10373065

7

V(H) gene analysis of IgM-secreting myeloma indicates an origin from a memory cell undergoing isotype switch events.

Sahota SS, Garand R, Mahroof R, Smith A, Juge-Morineau N, Stevenson FK, Bataille R. Sahota SS, et al. Among authors: juge morineau n. Blood. 1999 Aug 1;94(3):1070-6. Blood. 1999. PMID: 10419900 Free article.

8

High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cells.

Juge-Morineau N, Mellerin MP, Francois S, Rapp MJ, Harousseau JL, Amiot M, Bataille R. Juge-Morineau N, et al. Br J Haematol. 1995 Nov;91(3):664-7. doi: 10.1111/j.1365-2141.1995.tb05365.x. Br J Haematol. 1995. PMID: 8555072

9

Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells.

Pellat-Deceunynck C, Bataille R, Robillard N, Harousseau JL, Rapp MJ, Juge-Morineau N, Wijdenes J, Amiot M. Pellat-Deceunynck C, et al. Blood. 1994 Oct 15;84(8):2597-603. Blood. 1994. PMID: 7522634 Free article.

10

Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy.

Puthier D, Pellat-Deceunynck C, Barillé S, Robillard N, Rapp MJ, Juge-Morineau N, Harousseau JL, Bataille R, Amiot M. Puthier D, et al. Leukemia. 1999 Feb;13(2):289-94. doi: 10.1038/sj.leu.2401302. Leukemia. 1999. PMID: 10025904 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters